SARS-CoV-2 variants, vaccines, and host immunity
P Mistry, F Barmania, J Mellet, K Peta… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new beta coronavirus
that emerged at the end of 2019 in the Hubei province of China. SARS-CoV-2 causes …
that emerged at the end of 2019 in the Hubei province of China. SARS-CoV-2 causes …
Immunological considerations for COVID-19 vaccine strategies
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to …
respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to …
Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections
P Zimmermann, N Curtis - Archives of disease in childhood, 2021 - adc.bmj.com
In contrast to other respiratory viruses, children have less severe symptoms when infected
with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this …
with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this …
COVID-19 vaccines: The status and perspectives in delivery points of view
Due to the high prevalence and long incubation periods often without symptoms, the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …
COVID-19 and multisystem inflammatory syndrome in children and adolescents
As severe acute respiratory syndrome coronavirus 2 continues to spread worldwide, there
have been increasing reports from Europe, North America, Asia, and Latin America …
have been increasing reports from Europe, North America, Asia, and Latin America …
COVID-19: immunopathogenesis and Immunotherapeutics
L Yang, S Liu, J Liu, Z Zhang, X Wan… - Signal transduction and …, 2020 - nature.com
The recent novel coronavirus disease (COVID-19) outbreak, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected …
respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected …
Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis
Objective To evaluate association between biomarkers and outcomes in COVID-19
hospitalised patients. COVID-19 pandemic has been a challenge. Biomarkers have always …
hospitalised patients. COVID-19 pandemic has been a challenge. Biomarkers have always …
COVID‐19 diagnosis and management: a comprehensive review
G Pascarella, A Strumia, C Piliego… - Journal of internal …, 2020 - Wiley Online Library
Severe acute respiratory syndrome coronavirus (SARS‐CoV)‐2, a novel coronavirus from
the same family as SARS‐CoV and Middle East respiratory syndrome coronavirus, has …
the same family as SARS‐CoV and Middle East respiratory syndrome coronavirus, has …
Overview of immune response during SARS-CoV-2 infection: lessons from the past
After the 1918 flu pandemic, the world is again facing a similar situation. However, the
advancement in medical science has made it possible to identify that the novel infectious …
advancement in medical science has made it possible to identify that the novel infectious …
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
As a zoonotic disease that has already spread globally to several million human beings and
possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID‐19) …
possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID‐19) …